Ms. Antoinette Kathleen Schoonover, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 743 Main St, Rockwell City, IA 50579 Phone: 515-570-8569 |
Christina Jayne Kramer, PMHNP-BC Nurse Practitioner - Psych/Mental Health Medicare: Medicare Enrolled Practice Location: 401 Court St, Rockwell City, IA 50579 Phone: 712-297-2026 Fax: 712-297-2019 |
Mrs. Kylie Jane Hildreth-rothmeier, ARNP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 401 Court Street, Rockwell City, IA 50579 Phone: 712-297-2026 Fax: 712-297-2019 |
Janelle Elken, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 313 Lanedale # 7464, Rockwell City, IA 50579 Phone: 712-297-7521 |
Katie Riehl, Nurse Practitioner - Psych/Mental Health Medicare: Medicare Enrolled Practice Location: 130 Main St, Rockwell City, IA 50579 Phone: 515-570-1585 |
Sherry Sue Buske, ARNP Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 401 Court Street, Rockwell City, IA 50579 Phone: 712-297-2026 Fax: 712-297-2019 |
News Archive
Aastrom Biosciences, Inc., the leading developer of autologous cellular therapies for the treatment of severe cardiovascular diseases, today announced that the company will pursue a Phase 3 clinical program for its autologous cell therapy for the treatment of critical limb ischemia (CLI) through the U.S. Food and Drug Administration's special protocol assessment (SPA) process. Aastrom is currently completing a Phase 2b clinical trial of its cell therapy in patients with CLI and recently met with FDA officials to discuss plans for the Phase 3 program.
Scientists from the German Cancer Research Center and the Mannheim University Medical Center have now discovered that a certain group of cancer drugs (MEK Inhibitors) activates the cancer-promoting Wnt signaling pathway in colorectal cancer cells.
For the first time in a decade, the number of Americans without health insurance has risen — by about 2 million people in 2018 — according to the annual U.S. Census Bureau report released Tuesday.
Blood expression levels of genes targeted by the stress hormones called glucocorticoids could be a physical measure, or biomarker, of risk for developing Post-Traumatic Stress Disorder (PTSD), according to a study conducted in rats by researchers at the Icahn School of Medicine at Mount Sinai and published August 11 in Proceedings of the National Academy of Sciences (PNAS).
› Verified 4 days ago